Annals of Vascular Surgery

, Volume 6, Issue 4, pp 325–333 | Cite as

Early results of infrainguinal arterial reconstruction with a modified biological conduit

  • Willis H. Wagner
  • Phillip M. Levin
  • Richard L. Treiman
  • David V. Cossman
  • Robert F. Foran
  • J. Louis Cohen
Papers From The Southern California Vascular Surgery Society 1991 Meeting


We implanted 112 glutaraldehyde-fixed bovine carotid artery grafts (BioPolyMeric™ [BPM]) for infrainguinal reconstruction in 107 legs of 98 patients. Indications for surgery were disabling claudication in 28%, rest pain in 33% and tissue loss in 39%. In 32%, BPM bypass followed failed ipsilateral reconstruction. Autologous vein was either absent or inadequate in 60% of cases. BPM was used preferentially over vein in above-knee bypasses. The distal anastomosis was to the above-knee popliteal artery in 40%, to the below-knee popliteal artery in 35%, and to the tibial arteries in 25%. Follow-up was available from one to 25 months, with a mean of nine months. Wound complications developed after 9% of operations, including seven (6%) graft infections. Both patent grafts that became infected were salvaged. Four patients (4%) died within 60 days of surgery due to cardiac complications. Life-table primary and secondary patencies of all grafts were 64% and 65% at one year, and 48% and 62% at two years, respectively. The only factor significantly affecting graft patency was the location of the distal anastomosis (p<.01). Primary patencies at one and two years to the above-knee popliteal artery were 90% and 80%, to the below-knee popliteal artery were 56% and 37%, and to the infrapopliteal arteries were 34% and 26%. Bypass to 16% of extremities resulted in amputation, including 5% that were amputated with patent grafts. No limb loss occurred as a result of operation for claudication. In conclusion, BPM grafts provide early results comparable to saphenous vein above the knee. Future randomization with synthetic grafts is necessary to define the role of BPM grafts below the knee.

Key words

BioPolyMeric grafts graft glutaraldehyde-fixed bovine carotid grafts infrainguinal arteries 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    KENT KC, WHITTEMORE AD, MANNICK JA. Short-term and midterm results of an all-autologous tissue policy for infrainguinal reconstruction.J Vasc Surg 1989;9:107–114.CrossRefPubMedGoogle Scholar
  2. 2.
    PRENDIVILLE EJ, YEAGER A, O'DONNELL TF, et al. Long-term results with the above-knee popliteal expanded polytetrafluoroethylene graft.J Vasc Surg 1990;11:517–524.CrossRefPubMedGoogle Scholar
  3. 3.
    QUINONES-BALDRICH WJ, BUSUTTIL RW, BAKER JD, et al. Is the preferential use of polytetrafluoroethylene grafts for femoropopliteal bypass justified?J Vasc Surg 1988;8:219–228.CrossRefPubMedGoogle Scholar
  4. 4.
    SALLES-CUNHA SX, ANDROS G, HARRIS RW, et al. Preoperative noninvasive assessment of arm veins to be used as bypass grafts in the lower extremities.J Vasc Surg 1986;3:813–816.CrossRefPubMedGoogle Scholar
  5. 5.
    SEEGER JM, SCHMIDT JH, FLYNN TC. Preoperative saphenous and cephalic vein mapping as an adjunct to reconstructive arterial surgery.Ann Surg 1987;205:733–739.PubMedGoogle Scholar
  6. 6.
    DALMAN RL, TAYLOR LM. Basic data related to infrainguinal revascularization procedures.Ann Vasc Surg 1990;4:309–312.CrossRefPubMedGoogle Scholar
  7. 7.
    LONDREY GL, RAMSEY DE, HODGSON, et al. Infrapopliteal bypass for severe ischemia: comparison of autogenous vein, composite, and prosthetic grafts.J Vasc Surg 1991;13:631–636.CrossRefPubMedGoogle Scholar
  8. 8.
    RAFFERTY TD, AVELLONE JC, FARRELL CJ, et al. A metropolitan experience with infrainguinal revascularization: operative risk and late results in northeastern Ohio.J Vasc Surg 1987;6:365–371.CrossRefPubMedGoogle Scholar
  9. 9.
    WHITTEMORE AD, KENT KC, DONALDSON MC, et al. What is the proper role of polytetrafluoroethylene grafts in infrainguinal reconstruction?J Vasc Surg 1989;10:299–305.CrossRefPubMedGoogle Scholar
  10. 10.
    IGO SR, MEADOR JW, FRAZIER OH. Comparativein vitro evaluations of vascular graft compliance during dynamic loading.Trans Am Soc Artif Intern Organs 1988;34:785–788.Google Scholar
  11. 11.
    CRANLEY JJ, HAFNER CD. Revascularization of the femoropopliteal arteries using saphenous vein, polytetrafluoroethylene, and umbilical vein grafts.Arch Surg 1982;117:1543–1550.PubMedGoogle Scholar
  12. 12.
    EICKHOFF JH, BROOME A, ERICSSON BF, et al. Four years' results of a prospective, randomized clinical trial comparing polytetrafluoroethylene and modified human umbilical vein for below-knee femoropopliteal bypass.J Vasc Surg 1987;6:506–511.CrossRefPubMedGoogle Scholar
  13. 13.
    DARDIK H, MILLER N, DARDIK A, et al. A decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb.J Vasc Surg 1988;7:336–346.CrossRefPubMedGoogle Scholar
  14. 14.
    HASSON JE, NEWTON WD, WALTMAN AC, et al. Mural degeneration in the glutaraldehyde-tanned umbilical vein graft: incidence and implications.J Vasc Surg 1986;4:243–250.CrossRefPubMedGoogle Scholar
  15. 15.
    KARKOW WS, CRANLEY JC, CRANLEY RD, et al. Extended study of aneurysm formation in umbilical vein grafts.J Vasc Surg 1986;4:486–492.CrossRefPubMedGoogle Scholar
  16. 16.
    SAWYER PN, FITZGERALD J, KAPLITT MJ, et al. Ten year experience with the negatively charged glutaraldehydetanned graft in peripheral vascular surgery.Am J Surg 1987;154:533–537.CrossRefPubMedGoogle Scholar
  17. 17.
    RUTHERFORD RB, FLANIGAN DP, GUPTA SK, et al. Suggested standards for reports dealing with lower extremity ischemia.J Vasc Surg 1986;4:80–94.CrossRefPubMedGoogle Scholar
  18. 18.
    Product insert BioPolyMeric™ graft. St. Jude Medical, Minneapolis, Minnesota.Google Scholar
  19. 19.
    COSSMAN DV, ELLISON JE, WAGNER WH, et al. Comparison of contrast arteriography to arterial mapping with color-flow duplex imaging in the lower extremities.J Vasc Surg 1989;10:522–529.CrossRefPubMedGoogle Scholar
  20. 20.
    PETO R, PIKE MC, ARMITAGE P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.Br J Cancer 1976;34:585–612.PubMedGoogle Scholar
  21. 21.
    PETO R, PIKE MC, ARMITAGE P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples.Br J Cancer 1977;35:1–39.PubMedGoogle Scholar
  22. 22.
    MATTHEWS DE, FAREWELL VT. The log-rank or Mantel-Haenszel test for the comparison of survival curves. In: MATTHEWS DE, FAREWELL VT (eds).Using and understanding medical statistics, Second Edition. Basel: Karger, 1988, pp 79–87.Google Scholar
  23. 23.
    ABBOTT WM, MEGERMAN J, HASSON JE, et al. Effect of compliance mismatch on vascular graft patency.J Vasc Surg 1987;5:376–382.CrossRefPubMedGoogle Scholar
  24. 24.
    KIDSON IG, ABBOTT WM. Low arterial compliance and arterial graft occlusion.Circulation 1978;58:11–4.Google Scholar
  25. 25.
    MEGERMAN J, ABBOTT WM. Compliance in vascular grafts. In: WRIGHT C (ed). Vascular grafting. Littleton, Mass: Wright-PSG, 1983, pp 344–364.Google Scholar
  26. 26.
    SUGGS WD, HENRIQUES HF, DEPALMA RG. Vein cuff interposition prevents juxta-anastomotic neointimal hyperplasia.Ann Surg 1988;207:717–723.PubMedGoogle Scholar
  27. 27.
    RUTHERFORD RB, JONES DN, BERGENTZ, et al. Factors affecting the patency of infrainguinal bypass.J Vasc Surg 1988;8:236–246.CrossRefPubMedGoogle Scholar
  28. 28.
    ASCER E, COLLIER P, GUPTA S, et al. Reoperation for polytetrafluoroethylene bypass failure. The importance of distal outflow site and operative technique in determining outcome.J Vasc Surg 1987;5:298–310.CrossRefPubMedGoogle Scholar
  29. 29.
    DENNIS JW, LITTOOY FN, GREISLER HP, et al. Secondary vascular procedures with polytetrafluoroethylene grafts for lower extremity ischemia in a male veteran population.J Vasc Surg 1988;8:137–142.CrossRefPubMedGoogle Scholar
  30. 30.
    QUINONES-BALDRICH WJ, PREGO A, UCELAY-GOMEZ R, et al. Failure of PTFE infrainguinal revascularization: patterns, management alternative, and outcome.Ann Vasc Surg 1991;5:163–169.PubMedGoogle Scholar
  31. 31.
    ARFIDSSON B, LUBDGREN F, DROTT C, et al. Influence of coumarin treatment on patency and limb salvage after peripheral arterial reconstructive surgery.Am J Surg 1990;159:556–560.PubMedGoogle Scholar
  32. 32.
    FLINN WR, ROHRER MJ, YAO JST, et al. Improved long-term patency of infragenicular polytetrafluoroethylene grafts.J Vasc Surg 1988;7:685–690.CrossRefPubMedGoogle Scholar
  33. 33.
    LORENTZEN JE, NIELSEN OM, ARENDRUP, et al. Vascular graft infection: an analysis of sixty-two graft infections in 2411 consecutively implanted synthetic vascular grafts.Surgery 1985;98:81–86.PubMedGoogle Scholar
  34. 34.
    RUBIN JR, FOLSOM D. The management of lower extremity graft infections.Semin Vasc Surg 1990;3:114–121.Google Scholar
  35. 35.
    JARRETT F, HIRSCH SA. Reoperation for complications of stabilized human umbilical vein grafts.Am J Surg 1989;158:438–442.CrossRefPubMedGoogle Scholar

Copyright information

© Annals of Vascular Surgery Inc 1992

Authors and Affiliations

  • Willis H. Wagner
    • 1
  • Phillip M. Levin
    • 1
  • Richard L. Treiman
    • 1
  • David V. Cossman
    • 1
  • Robert F. Foran
    • 1
  • J. Louis Cohen
    • 1
  1. 1.From the Division of Vascular SurgeryCedars-Sinai Medical CenterLos Angeles

Personalised recommendations